top of page

BioNSW Commercialisation Breakfast

Wed, 17 June

|

Pfizer Australia

Recent Federal Budget proposals could significantly impact Australia’s innovation ecosystem, making it more challenging for life science founders to build companies. With government consultation now underway, this breakfast seminar will focus on how founders can actively influence policy outcomes.

BioNSW Commercialisation Breakfast
BioNSW Commercialisation Breakfast

Time & Location

17 June 2026, 8:00 am – 10:00 am AEST

Pfizer Australia, Level 15/18, 151 Clarence St, Sydney NSW 2000, Australia

About the event

Shaping the Future of Life Sciences Policy in Australia


Recent Federal Budget proposals have sparked significant discussion across Australia’s innovation sector, with potential implications for how life sciences companies are funded, built, scaled, and ultimately commercialised. While the proposed changes may present new challenges for founders and investors, the government's commitment to a consultation process creates an important opportunity for industry engagement.


Join fellow founders, executives, investors, and industry leaders for an informative and action-focused breakfast seminar exploring how the life sciences sector can play a more active role in shaping policy outcomes.


Moderated by life sciences founder and industry luminary Jeremy Chrisp, this event will feature a comprehensive unpacking of the proposed tax reforms by Matt McCarthy, Director | Global Investment, Deloitte, who will examine the implications for founders, investors, and Australia's broader innovation ecosystem.


The discussion will be followed by a blockbuster panel exploring the key questions and challenges…


Tickets

  • General Admission - Members

    $0.00

    Sold Out
  • General Admission

    $30.00

    +$0.75 ticket service fee

Total

$0.00

Share this event

bottom of page